Bavarian Nordic considers 24-Hour emergency production of monkeypox shot
Skyrocketing demand for the world’s only approved monkeypox vaccine means its maker, Bavarian Nordic, is thinking of new ways to ramp up production. Running machinery through the night is an option, the firm says.
By Christian Wienberg with assistance from James Cone, bloomberg
Bavarian Nordic A/S, the only company with a vaccine approved for monkeypox, said it’s preparing to run production through the night to meet surging demand after the virus outbreak was declared a global emergency.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Analyst: Bavarian Nordic continues hot streak
For subscribers
WHO declares monkeypox global health emergency
For subscribers
.jpg)
.jpg&w=384&q=75)
